MetaADEDB 2.0 @ LMMD
doxylamine succinate
(KBAUFVUYFNWQFM-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)CCC(=O)O.CN(CCOC(c1ccccn1)(c1ccccc1)C)C
Molecular Formula:
C21H28N2O5
Molecular Weight:
388.457
Log P:
2.8591
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
99.96
CAS Number(s):
562-10-7
Synonym(s)
1.
doxylamine succinate
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1OverdoseFAERS: 53US FAERS
2SomnolenceFAERS: 34US FAERS
3Drug ineffectiveFAERS: 26US FAERS
4Incorrect dose administeredFAERS: 26US FAERS
5Suicide attemptFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
6DizzinessFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
7VomitingFAERS: 15US FAERS
8Feeling abnormalFAERS: 12US FAERS
9TremorFAERS: 10US FAERS
10RhabdomyolysisFAERS: 8US FAERS
11AgitationFAERS: 6US FAERS
12Drug DependenceFAERS: 6US FAERS
13Drug exposure during pregnancyFAERS: 6US FAERS
14Medication ErrorFAERS: 6US FAERS
15MydriasisFAERS: 6US FAERS
16DysarthriaFAERS: 5US FAERS
17Expired product administeredFAERS: 5US FAERS
18FatigueFAERS: 5US FAERS
19Intentional misuseFAERS: 5US FAERS
20Toxicity to various agentsFAERS: 5US FAERS
21AnxietyFAERS: 4US FAERS
22Completed SuicideFAERS: 4US FAERS
23Depressed Level of ConsciousnessFAERS: 4US FAERS
24HypersomniaFAERS: 4US FAERS
25Incorrect drug administration durationFAERS: 4US FAERS
26LethargyFAERS: 4US FAERS
27TachycardiaFAERS: 4US FAERS
28Accidental exposureFAERS: 3US FAERS
29Accidental overdoseFAERS: 3US FAERS
30AmnesiaFAERS: 3US FAERS
31Drug screen positiveFAERS: 3US FAERS
32HypotensionFAERS: 3US FAERS
33IncoherentFAERS: 3US FAERS
34Intentional drug misuseFAERS: 3US FAERS
35MalaiseFAERS: 3US FAERS
36PalpitationsFAERS: 3US FAERS
37Wrong technique in product usage processFAERS: 3US FAERS
38Abdominal discomfortFAERS: 2US FAERS
39Accidental drug intake by childFAERS: 2US FAERS
40AphasiaFAERS: 2US FAERS
41AstheniaFAERS: 2US FAERS
42Chest PainFAERS: 2US FAERS
43DisorientationFAERS: 2US FAERS
44DyspepsiaFAERS: 2US FAERS
45FlushingFAERS: 2US FAERS
46HeadacheFAERS: 2US FAERS
47LeukocytosisFAERS: 2US FAERS
48Musculoskeletal PainFAERS: 2US FAERS
49NauseaFAERS: 2US FAERS
50NervousnessFAERS: 2US FAERS
51ParanoiaFAERS: 2US FAERS
52PruritusFAERS: 2US FAERS
53Sleep TalkingFAERS: 2US FAERS
54TinnitusFAERS: 2US FAERS
55Wrong technique in drug usage processFAERS: 2US FAERS
56AbasiaFAERS: 1US FAERS
57Accidental exposure to productFAERS: 1US FAERS
58Accidental exposure to product by childFAERS: 1US FAERS
59AngerFAERS: 1US FAERS
60Anticholinergic SyndromeFAERS: 1US FAERS
61ArthralgiaFAERS: 1US FAERS
62Back PainFAERS: 1US FAERS
63Bipolar DisorderFAERS: 1US FAERS
64Blood chloride decreasedFAERS: 1US FAERS
65Blood creatine phosphokinase increasedFAERS: 1US FAERS
66Blood creatinine increasedFAERS: 1US FAERS
67Blood glucose increasedFAERS: 1US FAERS
68Blood growth hormone abnormalFAERS: 1US FAERS
69Blood lactate dehydrogenase increasedFAERS: 1US FAERS
70Blood pH decreasedFAERS: 1US FAERS
71Blood pH increasedFAERS: 1US FAERS
72Blood sodium decreasedFAERS: 1US FAERS
73Blood urine presentFAERS: 1US FAERS
74BronchospasmFAERS: 1US FAERS
75Cerebellar AtaxiaFAERS: 1US FAERS
76CryingFAERS: 1US FAERS
77DependenceFAERS: 1US FAERS
78Drug abuseFAERS: 1US FAERS
79Drug administration errorFAERS: 1US FAERS
80Drug effect variableFAERS: 1US FAERS
81Drug toxicityFAERS: 1US FAERS
82DysuriaFAERS: 1US FAERS
83Emotional disorderFAERS: 1US FAERS
84EpistaxisFAERS: 1US FAERS
85Feeling jitteryFAERS: 1US FAERS
86FlatulenceFAERS: 1US FAERS
87Foreign body traumaFAERS: 1US FAERS
88HyperpyrexiaFAERS: 1US FAERS
89HypersensitivityFAERS: 1US FAERS
90HyperventilationFAERS: 1US FAERS
91Impaired driving abilityFAERS: 1US FAERS
92Inappropriate schedule of drug administrationFAERS: 1US FAERS
93Inappropriate schedule of product administrationFAERS: 1US FAERS
94Mental RetardationFAERS: 1US FAERS
95Middle insomniaFAERS: 1US FAERS
96Mood swingsFAERS: 1US FAERS
97Musculoskeletal stiffnessFAERS: 1US FAERS
98MyalgiaFAERS: 1US FAERS
99Myocardial InfarctionFAERS: 1US FAERS
100Negative thoughtsFAERS: 1US FAERS
101Night sweatsFAERS: 1US FAERS
102No adverse eventFAERS: 1US FAERS
103NystagmusFAERS: 1US FAERS
104OliguriaFAERS: 1US FAERS
105Oropharyngeal painFAERS: 1US FAERS
106PetechiaeFAERS: 1US FAERS
107PoisoningFAERS: 1US FAERS
108Product formulation issueFAERS: 1US FAERS
109ProteinuriaFAERS: 1US FAERS
110Rash erythematousFAERS: 1US FAERS
111ScreamingFAERS: 1US FAERS
112Self-induced vomitingFAERS: 1US FAERS
113Sinus TachycardiaFAERS: 1US FAERS
114Skin reactionFAERS: 1US FAERS
115SnoringFAERS: 1US FAERS
116SomnambulismFAERS: 1US FAERS
117Status EpilepticusFAERS: 1US FAERS
118Stevens-Johnson SyndromeFAERS: 1US FAERS
119SyncopeFAERS: 1US FAERS
120ThrombosisFAERS: 1US FAERS
121Tongue bitingFAERS: 1US FAERS
122Unevaluable eventFAERS: 1US FAERS
123Urinary RetentionFAERS: 1US FAERS
124Vascular resistance pulmonary decreasedFAERS: 1US FAERS
125Vascular resistance systemic decreasedFAERS: 1US FAERS
126VertigoFAERS: 1US FAERS
127Fatty Liver3356310CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.